A recent study reveals that patients who come off new GLP-1 drugs like Wegovy and Mounjaro may regain lost weight much more quickly than those who end traditional diet and exercise regimens.
Published data in a major medical journal points out that while obese people frequently drop about a fifth of their total mass while using the jabs, the mass returns at an average rate of nearly a kilo each month after stopping.
"Users purchasing these medications need to be cognizant of the potential of fast weight regain when the medication is stopped," warns expert Dr. Susan Jebb.
This pace of regain implies a reversion to pre-treatment mass within about a year and a half.
Weighing Therapies
The analysis, which looked at dozens of trials involving thousands of patients, contrasted the effects of GLP-1 agonists with other pills.
The team point out that people who lose weight through diet and exercise usually experience a slower creep back—approximately 100 grams monthly—post-intervention.
The Reason for the Fast Rebound
Doctors suggest the way of the jabs accounts for the heightened regain.
The injections copy a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Artificially providing the hormone concentrations far above than normal might result in the system to generate a reduced amount of its endogenous hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication leads to appetite is unsuppressed, making excessive eating a significant risk."
A Lifelong Issue?
The NHS suggest the injections for people with obesity-related health risks, alongside prescribed lifestyle changes.
Many experts contend that, considering the likelihood of relapse, the treatment is often ongoing.
This view is echoed by pharmaceutical companies, who say that the results "emphasize the long-term nature of obesity," akin to managing diseases like high blood pressure.
Patient Accounts
Individuals who have discontinued the jabs describe a powerful resurgence of hunger.
"It felt as if a switch flipping and you're instantly extremely hungry," described one woman.
This challenge is compounded if patients have not adopted sustainable lifestyle or habit changes during therapy.
Widespread Interest
Figures show that a significant number of adults in the UK have used these injections in the last 12 months, with demand continuing to grow.
- Use is higher among females compared to males.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion obtain the medications through private healthcare rather than public health services.
Ultimately, experts emphasize that while GLP-1 drugs are potent tools for shedding pounds, they are not a magic cure and maintained weight loss relies on ongoing lifestyle changes.